Results 1 to 10 of about 213,641 (283)

Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016? [Elektronisk resurs]

open access: yes, 2016
Recent news of an impending clinical cell transplantation trial in Parkinson's disease using parthenogenetic stem cells as a source of donor tissue have raised hopes in the patient community and sparked discussion in the research community.
Brundin, Patrik,   +6 more
core   +1 more source

Population-based studies on the epidemiology of migraine and Parkinson's disease [PDF]

open access: yes, 2007
With epidemiologic analyses the effect of certain exposures on diseases can be studied in large population samples. Pharmacoepidemiology is a speciality which focuses on beneficial or harmful drug effects on the development of diseases.
Becker, Claudia
core   +1 more source

Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale

open access: yes, 2017
In Parkinson's disease, pain is a prevalent and complex symptom of diverse origin. King's Parkinson's disease pain scale, assesses different pain syndromes, thus allowing exploration of its differential prevalence and influence on the health-related ...
Rizos, Alexandra,   +29 more
core   +1 more source

Parkinson's Disease

open access: yes, 2022
Parkinson’s disease is a common progressive neurodegenerative disease of the dopaminergic neurons within the substantia nigra pars compacta resulting in an altered motor movement.
Kakish, Diala Ra'Ed Kamal
core  

Atrophic Myenteric and Submucosal Neurons Are Observed in Parkinson's Disease [Elektronisk resurs]

open access: yes, 2019
Aim. Parkinson's disease is often accompanied by gastrointestinal symptoms, especially constipation. Microscopic studies of the enteric nervous system and enteric neuropathy have often been performed by immunostaining in the myenteric plexa.
Englund, Elisabet,   +2 more
core   +1 more source

Parkinson's disease [PDF]

open access: yesThe Lancet, 2004
Parkinson's disease is the most common serious movement disorder in the world, affecting about 1% of adults older than 60 years. The disease is attributed to selective loss of neurons in the substantia nigra, and its cause is enigmatic in most individuals.
Samii, Ali   +2 more
openaire   +3 more sources

Visual exploration in Parkinson's disease and Parkinson's disease dementia [PDF]

open access: yes, 2013
Parkinson's disease, typically thought of as a movement disorder, is increasingly recognized as causing cognitive impairment and dementia. Eye movement abnormalities are also described, including impairment of rapid eye movements (saccades) and the ...
Archibald, Neil K.   +4 more
core   +1 more source

Stem Derived Dopamine Neurons Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease?

open access: yes, 2021
The use of stem cell derived dopamine neurons for treating patients with Parkinson's disease has now evolved to the first in human clinical trials.
Barker, Roger A,   +4 more
core   +1 more source

Biallelic expansion in RFC1 as a rare cause of Parkinson's disease

open access: yes, 2022
An intronic expansion (AAGGG)(exp) in the RFC1 gene has recently been shown to cause recessively inherited cerebellar ataxia, neuropathy, and vestibular areflexia syndrome and, furthermore, a few patients with ataxia and parkinsonism have been reported ...
Tanaka Fumiaki   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy